ASP Isotopes (NASDAQ:ASPI) Sees Large Volume Increase – Still a Buy?

Shares of ASP Isotopes Inc. (NASDAQ:ASPI) saw strong trading volume on Thursday . 1,574,202 shares traded hands during mid-day trading, an increase of 32% from the previous session’s volume of 1,193,284 shares.The stock last traded at $7.83 and had previously closed at $6.90.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on ASPI shares. Canaccord Genuity Group reaffirmed a “buy” rating and set a $4.50 price target on shares of ASP Isotopes in a research report on Friday, October 18th. HC Wainwright cut their target price on shares of ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Finally, Canaccord Genuity Group initiated coverage on shares of ASP Isotopes in a research report on Friday, October 4th. They issued a “buy” rating and a $4.50 price target on the stock.

ASP Isotopes Stock Performance

The company has a quick ratio of 4.00, a current ratio of 4.00 and a debt-to-equity ratio of 2.06. The company has a market capitalization of $532.91 million, a PE ratio of -12.37 and a beta of 5.11. The company has a 50-day moving average price of $3.36 and a two-hundred day moving average price of $3.39.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Monday, August 19th. The company reported ($0.24) earnings per share for the quarter. The business had revenue of $1.02 million during the quarter. Analysts predict that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

Institutional Trading of ASP Isotopes

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of ASP Isotopes by 479.1% during the 1st quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock valued at $4,217,000 after purchasing an additional 844,705 shares in the last quarter. Marshall Wace LLP grew its position in ASP Isotopes by 389.6% during the second quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock worth $1,668,000 after buying an additional 433,734 shares in the last quarter. Fiera Capital Corp bought a new position in ASP Isotopes in the 3rd quarter worth about $723,000. Rathbones Group PLC increased its stake in ASP Isotopes by 27.5% in the 2nd quarter. Rathbones Group PLC now owns 195,915 shares of the company’s stock worth $600,000 after acquiring an additional 42,243 shares during the last quarter. Finally, Renaissance Technologies LLC raised its holdings in shares of ASP Isotopes by 5.7% in the 2nd quarter. Renaissance Technologies LLC now owns 171,800 shares of the company’s stock valued at $526,000 after acquiring an additional 9,200 shares in the last quarter. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.